Rona Therapeutics
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-10-13 | Roche | ALK7-targeting RNAi candidate | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-10-13 | Roche | ALK7-targeting RNAi candidate | Not disclosed | Not disclosed | Not disclosed | Not disclosed |